Additional 5 Years of AI Treatment Reduces Distant Recurrence Rates Among Postmenopausal Women Already Treated with at Least 5 Years of Endocrine Therapy By Ogkologos - August 25, 2025 608 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a meta-analysis performed by the Early Breast Cancer Trialists’ Collaborative Group Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors Adding Belzutifan to Pembrolizumab Prolongs DFS After Nephrectomy in Patients with ccRCC at Increased Risk for Recurrence MOST POPULAR Combination of Azacitidine and Venetoclax in Previously Untreated AML August 18, 2020 Helping Dogs—and Humans—with Cancer: NCI’s Comparative Oncology Studies July 10, 2019 Ending smoking could free up 75,000 GP appointments each month March 7, 2023 Analysis Shows Women with High Breast Cancer Recurrence Scores Benefit from... October 24, 2019 Load more HOT NEWS Man Gets His First Haircut In 15 Years To Join The... Synchronized Swimmer Learns She Has Breast Cancer After Teammate Kicks Her... Marine Runs Five Marathons in Five Days to Help Fund Sister’s... The Appraisal – Scientific disruption: what is it, and do we...
